FDA Approves World’s First Crispr Gene-Editing Drug for Sickle-Cell Disease
www.wsj.com
The U.S. has approved the world’s first medicine employing Crispr technology, a Nobel Prize-winning discovery that promised a powerful new tool to treat disease.

The key thing about this kind of therapy is that it’s not a drug you keep on taking - it’s a one-time thing which permanently cures the disease.